Microbial-Biotechnology
Microorganisms are performing many chemical reactions. This ability are often applied for the assembly of commercial chemicals. It provide solutions to efficiently convert
biomass into chemicals and fuels using microorganisms. Genetic techniques enable us to switch the
microbial metabolism. Our objective is to adapt the
microbial metabolism, so that the product is produced at maximum theoretical yield, whereas also ATP is produced to support growth and maintenance.
Microbial biotechnology or industrial
microbiology is the use of microorganisms to obtain an economically valuable product or activity at a commercial or large scale. The microorganisms used in industrial processes are natural, laboratory-selected mutant or genetically engineered strains. Economically valuable products such as alcohols, solvents, organic acids, amino acids, enzymes, fermented dairy products, food additives, vitamins, antibiotics, recombinant proteins and hormones, biopolymers, fertilizers, and biopesticides are produced by microorganisms that are used in chemical, food, pharmaceutical, agricultural, and other industries.
Biodegradation and
biotransformation of complex compounds, domestic and industrial wastewater treatment, biomining, and
enhanced oil recovery are samples of microbially valuable activities. According to the UN Convention on Biological Diversity,
microbial biotechnology are often dened as any technological application that uses microbiological systems,
microbial organisms, or derivatives thereof, to form or modify products or processes for specic use.
High Impact List of Articles
-
Influence of photomodulation on the structural and energetically state of water and its biological activity
Konstantin Pronko, Vladimir Zemskov*, Anatoly Stekhin, Galina Yakovleva, Aleksandr Marasanov and Aleksandr Karasev
Research Article: Clinical Practice
-
Influence of photomodulation on the structural and energetically state of water and its biological activity
Konstantin Pronko, Vladimir Zemskov*, Anatoly Stekhin, Galina Yakovleva, Aleksandr Marasanov and Aleksandr Karasev
Research Article: Clinical Practice
-
Insurance Health companies of a southern region of Colombia: Company behavior and survival 2012-2016
Cristian R, Ana MR, Roa PJ, Katherin TP, Jose D. Charry*
Research Article: Clinical Practice
-
Insurance Health companies of a southern region of Colombia: Company behavior and survival 2012-2016
Cristian R, Ana MR, Roa PJ, Katherin TP, Jose D. Charry*
Research Article: Clinical Practice
-
Evidence-based chemotherapeutic management of potentially platinum‑sensitive recurrent ovarian cancer
Maurie Markman
Opinion Article: Clinical Practice
-
Evidence-based chemotherapeutic management of potentially platinum‑sensitive recurrent ovarian cancer
Maurie Markman
Opinion Article: Clinical Practice
-
Antimalarial drug quality: methods to detect suspect drugs
Harparkash Kaur, Michael D Green, Dana M Hostetler, Facundo M Fernandez and Paul N Newton
Review Article: Clinical Practice
-
Antimalarial drug quality: methods to detect suspect drugs
Harparkash Kaur, Michael D Green, Dana M Hostetler, Facundo M Fernandez and Paul N Newton
Review Article: Clinical Practice
-
Tamsulosin modified-release and oral-controlled absorption system formulations in the treatment of benign prostatic hyperplasia
Marleen M van Dijk, Jean JMCH de la Rosette and Martin C Michel
Drug Evaluation: Clinical Practice
-
Tamsulosin modified-release and oral-controlled absorption system formulations in the treatment of benign prostatic hyperplasia
Marleen M van Dijk, Jean JMCH de la Rosette and Martin C Michel
Drug Evaluation: Clinical Practice
-
The role of endobronchial ultrasound in diagnosis, staging and treatment
Felix JF Herth and Ralf Eberhardt
Short Report: Clinical Practice
-
The role of endobronchial ultrasound in diagnosis, staging and treatment
Felix JF Herth and Ralf Eberhardt
Short Report: Clinical Practice
-
The mutant prevention concentration as a strategy to minimize antimicrobial resistance- a timely concept but will it\'s acceptance be too late?
Glen T Hansen and Joseph M Blondeau
Short Report: Clinical Practice
-
The mutant prevention concentration as a strategy to minimize antimicrobial resistance- a timely concept but will it\'s acceptance be too late?
Glen T Hansen and Joseph M Blondeau
Short Report: Clinical Practice
Relevant Topics in Clinical